A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...
Postpartum depression (PPD) is depression that occurs after giving birth for up to 12 months. It is a serious disorder affecting 10-20% of mothers (Khadka, 2024). For most cases of mild to moderate ...
Please provide your email address to receive an email when new articles are posted on . Postpartum depression is the most common childbirth complication in the U.S. More providers and women are ...
Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. The birth of a child comes with a swirl of positive emotions: awe, joy, relief. And yet, ...
In a recent study published in eClinicalMedicine, researchers conducted a meta-analysis to investigate the efficacy and safety of zuranolone in treating major depressive disorder (MDD). Specifically, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results